Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications

被引:3
|
作者
Wu, Zhili [1 ,2 ]
Zhu, Yanru [1 ,2 ]
Liu, Wenchao [3 ]
Balasubramanian, Balamuralikrishnan [4 ]
Xu, Xiao [5 ]
Yao, Junhu [1 ,2 ]
Lei, Xinjian [1 ,2 ]
机构
[1] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China
[2] Northwest A&F Univ, Key Lab Livestock Biol, Yangling 712100, Peoples R China
[3] Guangzhou Ocean Univ, Coll Coastal Agr Sci, Zhanjiang 524088, Peoples R China
[4] Sejong Univ, Dept Food Sci & Biotechnol, Coll Life Sci, Seoul 05006, South Korea
[5] Wuhan Polytech Univ, Sch Anim Sci & Nutr Engn, Wuhan 430023, Peoples R China
基金
中国国家自然科学基金;
关键词
ferroptosis; natural active compounds; liver disease; therapeutic implications; IRON HOMEOSTASIS; CELL-DEATH; IN-VIVO; ACTIVATION; MECHANISMS; FIBROSIS; CANCER; ANTIOXIDANT; PROTECTS; PATHWAY;
D O I
10.3390/antiox13030352
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ferroptosis is an emerging type of regulated cell death usually accompanied by the accumulation of ferrous ions (Fe2+) and lipid peroxides. As the metabolic hub of the body, the liver is crucial for iron storage and lipid metabolism. The liver seems to be closely related to ferroptosis through iron and lipid metabolism. Liver disease greatly threatens host health, and exploring effective interventions is essential. Mounting studies have demonstrated that ferroptosis is one of the possible pathogenic mechanisms involved in liver disease. Targeting ferroptosis may provide a promising opportunity for treating liver disease. However, drugs targeting ferroptosis are extremely limited. Therefore, it is an urgent need to develop new and safe ferroptosis regulators. Natural active compounds (NAC), especially those derived from traditional Chinese medicine, have recently shown great therapeutic potential in liver disease via modulating ferroptosis-related genes or pathways. Here, we outline the molecular mechanism of ferroptosis and systematically summarize the regulatory function of NAC on ferroptosis in liver disease. Finally, we discuss the application prospects and potential problems concerning NAC as ferroptosis regulators for managing liver disease.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option?
    Bieri, Shania
    Moller, Burkhard
    Amsler, Jennifer
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [22] Ferroptosis as a new therapeutic opportunity for nonviral liver disease
    Jia, Min
    Zhang, Hongmei
    Qin, Qiaohong
    Hou, Ying
    Zhang, Xin
    Chen, Di
    Zhang, Hong
    Chen, Yulong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 908
  • [23] Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
    Xu, Chuchu
    Chen, Yian
    Yu, Qinghong
    Song, Jiaqing
    Jin, Ying
    Gao, Xiufei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] The Role of Ferroptosis and Cuproptosis in Tuberculosis Pathogenesis: Implications for Therapeutic Strategies
    Dawi, John
    Affa, Stephen
    Kafaja, Kevin
    Misakyan, Yura
    Kades, Samuel
    Dayal, Surbi
    Fardeheb, Sabrina
    Narasimhan, Ananya
    Tumanyan, Kevin
    Venketaraman, Vishwanath
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (02)
  • [25] Natural Flavonoids and Ferroptosis: Potential Therapeutic Opportunities for Human Diseases
    Zhou, Zheng
    Li, Jiye
    Zhang, Xiaochuan
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (15) : 5902 - 5916
  • [26] MicroRNA-mediated regulation of Ferroptosis: Implications for disease pathogenesis and therapeutic interventions
    Razi, Shokufeh
    Khojini, Javad Yaghmoorian
    Norioun, Hamid
    Hayati, Mohammad Javad
    Naseri, Nasim
    Tajbaksh, Amir
    Gheibihayat, Seyed Mohammad
    CELLULAR SIGNALLING, 2025, 125
  • [27] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [28] Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases
    You, Hongmei
    Wang, Ling
    Bu, Fangtian
    Meng, Hongwu
    Huang, Cheng
    Fang, Guoying
    Li, Jun
    CELLS, 2022, 11 (20)
  • [29] Ferroptosis in Cardiovascular Disease and Cardiomyopathies: Therapeutic Implications of Glutathione and Iron Chelating Agents
    Dawi, John
    Affa, Scarlet
    Gonzalez, Edgar
    Misakyan, Yura
    Nikoghosyan, David
    Hajjar, Karim
    Kades, Samuel
    Fardeheb, Sabrina
    Mirzoyan, Hayk
    Venketaraman, Vishwanath
    BIOMEDICINES, 2024, 12 (03)
  • [30] Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents
    Pandey, Pratibha
    Elsori, Deena
    Kumar, Rahul
    Lakhanpal, Sorabh
    Rautela, Indra
    Alqahtani, Tariq Mohammed
    Ahmad, Fuzail
    Iqbal, Danish
    Khan, Fahad
    FRONTIERS IN PHARMACOLOGY, 2024, 15